Sanofi | SNY - Fremdkapital

Aktienkurs
46.58
Täglich Wechseln
0.56 1.22%
Monatlich
-3.40%
Jährlich
-13.95%
Q2 Prognose
45.74




Fremdkapital Veränderung Datum
AbbVie USD 58.94B 4.03B 2025-12
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 25.96B 177M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Canopy Growth CAD 224.99M 1.34M 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Galapagos EUR 5.19M 574K 2025-12
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
Glaxosmithkline GBP 19.82B 203.13M 2025-12
J&J USD 37.53B 1.91B 2026-03
Merck USD 46.75B 6.78B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Sanofi EUR 15.72B 150.06M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
UCB EUR 2.18B 634M 2025-12
Zoetis USD 9.04B 1.97B 2025-12